Overview of the pathogenesis of COVID‑19 (Review)
- Authors:
- Chao Li
- Qifang He
- Hebu Qian
- Jun Liu
-
Affiliations: Department of Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China, Department of Critical Care Medicine, Suzhou Ninth People's Hospital, The Affiliated Wujiang Hospital of Nantong University, Suzhou, Jiangsu 215001, P.R. China - Published online on: July 15, 2021 https://doi.org/10.3892/etm.2021.10444
- Article Number: 1011
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Gates B: Responding to Covid-19 - A Once-in-a-century pandemic. N Engl J Med. 382:1677–1679. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al: Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 8:475–481. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Poston JT, Patel BK and Davis AM: Management of critically ill adults with COVID-19. JAMA. 323:1839–1841. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Maugeri G, Castrogiovanni P, Battaglia G, Pippi R, D'Agata V, Palma A, Di Rosa M and Musumeci G: The impact of physical activity on psychological health during Covid-19 pandemic in Italy. Heliyon. 6(e04315)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ravalli S and Musumeci G: Coronavirus outbreak in Italy: Physiological benefits of home-based exercise during pandemic. J Funct Morphol Kinesiol. 5(31)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, et al: Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 130:2620–2629. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT and Veesler D: Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 181:281–292.e6. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L and Wang X: Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 581:215–220. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A and Li F: Structural basis of receptor recognition by SARS-CoV-2. Nature. 581:221–224. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y and Li L: SARS-CoV-2: Virus dynamics and host response. Lancet Infect Dis. 20:515–516. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Pedersen SF and Ho YC: SARS-CoV-2: A storm is raging. J Clin Invest. 130:2202–2205. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yan R, Zhang Y, Li Y, Xia L, Guo Y and Zhou Q: . Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 367:1444–1448. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer MA and Solomon SD: Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 382:1653–1659. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lin L, Lu L, Cao W and Li T: Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 9:727–732. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Fu Y, Cheng Y and Wu Y: Understanding SARS-CoV-2-mediated inflammatory responses: From mechanisms to potential therapeutic tools. Virol Sin. 35:266–271. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zheng M and Song L: Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. Cell Mol Immunol. 17:536–538. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y and Ying T: Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 9:382–385. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Cao X: COVID-19: Immunopathology and its implications for therapy. Nat Rev Immunol. 20:269–270. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Arabi YM, Murthy S and Webb S: COVID-19: A novel coronavirus and a novel challenge for critical care. Intensive Care Med. 46:833–836. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 395:565–574. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al: A new coronavirus associated with human respiratory disease in China. Nature. 579:265–269. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al: Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 8:420–422. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Bermejo-Martin JF, Almansa R, Menéndez R, Mendez R, Kelvin DJ and Torres A: Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection. J Infect. 80:e23–e24. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tsatsakis A, Petrakis D, Nikolouzakis TK, Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis C, Aschner M and Hernández AF: COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence. Food Chem Toxicol. 141(111418)2020.PubMed/NCBI View Article : Google Scholar | |
|
Sarkar C, Mondal M, Torequl Islam M, Martorell M, Docea AO, Maroyi A, Sharifi-Rad J and Calina D: Potential therapeutic options for COVID-19: Current status, challenges, and future perspectives. Front Pharmacol. 11(572870)2020.PubMed/NCBI View Article : Google Scholar | |
|
Kwong KK and Chan ST: The role of carbon monoxide and heme oxygenase-1 in COVID-19. Toxicol Rep. 7:1170–1171. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A and Poulas K: Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep. 7:658–663. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Nasi A, McArdle S, Gaudernack G, Westman G, Melief C, Rockberg J, Arens R, Kouretas D, Sjölin J and Mangsbo S: Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention. Toxicol Rep. 7:768–771. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W and Haque U: The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned. Int J Epidemiol. 49:717–726. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S and Yuen KY: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 9:221–236. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Weiss SR and Leibowitz JL: Coronavirus pathogenesis. Adv Virus Res. 81:85–164. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Jimenez-Guardeño JM, Nieto-Torres JL, DeDiego ML, Regla-Nava JA, Fernandez-Delgado R, Castaño-Rodriguez C and Enjuanes L: The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis. PLoS Pathog. 10(e1004320)2014.PubMed/NCBI View Article : Google Scholar | |
|
Riou J and Althaus CL: Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 25(2000058)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wu JT, Leung K and Leung GM: Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. Lancet. 395:689–697. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Vink MA, Bootsma MC and Wallinga J: Serial intervals of respiratory infectious diseases: A systematic review and analysis. Am J Epidemiol. 180:865–875. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung K, Lau E, Wong JY, et al: Early transmission Ddynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 382:1199–1207. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, Lou Y, Gao D, Yang L, He D, et al: Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 92:214–217. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Munster VJ, Koopmans M, van Doremalen N, van Riel D and de Wit E: A novel coronavirus emerging in China-key questions for impact assessment. N Engl J Med. 382:692–694. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Swerdlow DL and Finelli L: Preparation for possible sustained transmission of 2019 novel coronavirus: Lessons from pevious epidemics. JAMA. 323:1129–1130. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, et al: SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 382:1177–1179. 2020.PubMed/NCBI View Article : Google Scholar | |
|
To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, et al: Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study. Lancet Infect Dis. 20:565–574. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, et al: Clinical and virological data of the first cases of COVID-19 in Europe: A case series. Lancet Infect Dis. 20:697–706. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Navas-Martín SR and Weiss S: Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. J Neurovirol. 10:75–85. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Skariyachan S, Challapilli SB, Packirisamy S, Kumargowda ST and Sridhar VS: Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for Middle East Respiratory Syndrome Coronavirus infections. Front Microbiol. 10(569)2019.PubMed/NCBI View Article : Google Scholar | |
|
van den Brand JM, Smits SL and Haagmans BL: Pathogenesis of Middle East respiratory syndrome coronavirus. J Pathol. 235:175–184. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Millet JK and Whittaker GR: Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res. 202:120–134. 2015.PubMed/NCBI View Article : Google Scholar | |
|
von der Thüsen J and van der Eerden M: Histopathology and genetic susceptibility in COVID-19 pneumonia. Eur J Clin Invest. 50(e13259)2020.PubMed/NCBI View Article : Google Scholar | |
|
Hanley B, Lucas SB, Youd E, Swift B and Osborn M: Autopsy in suspected COVID-19 cases. J Clin Pathol. 73:239–242. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Weiss SR and Navas-Martin S: Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 69:635–664. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, He L, Chen Y, Wu J, Shi Z, et al: Molecular Mechanism for antibody-dependent enhancement of coronavirus entry. J Virol. 94:e02015–19. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Letko M, Marzi A and Munster V: Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 5:562–569. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Davidson AM, Wysocki J and Batlle D: Interaction of SARS-CoV-2 and other coronavirus with ACE (Angiotensin-converting enzyme)-2 as their main receptor: Therapeutic implications. Hypertension. 76:1339–1349. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS and McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 367:1260–1263. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhou J, Chu H, Li C, Wong BH, Cheng ZS, Poon VK, Sun T, Lau CC, Wong KK, Chan JY, et al: Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis. J Infect Dis. 209:1331–1342. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G and van Goor H: Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 203:631–637. 2004.PubMed/NCBI View Article : Google Scholar | |
|
To KF and Lo AW: Exploring the pathogenesis of severe acute respiratory syndrome (SARS): The tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol. 203:740–743. 2004.PubMed/NCBI View Article : Google Scholar | |
|
He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, et al: Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS. J Pathol. 210:288–297. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Gu J, Han B and Wang J: COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 158:1518–1519. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Xiao F, Tang M, Zheng X, Liu Y, Li X and Shan H: Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 158:1831–1833.e3. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mak J, Chan F and Ng SC: Probiotics and COVID-19: One size does not fit all. Lancet Gastroenterol Hepatol. 5:644–645. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liang W, Feng Z, Rao S, Xiao C, Xue X, Lin Z, Zhang Q and Qi W: Diarrhoea may be underestimated: A missing link in 2019 novel coronavirus. Gut. 69:1141–1143. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, et al: Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 5:802–810. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen L, Li X, Chen M, Feng Y and Xiong C: The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 116:1097–1100. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Graham RL, Sparks JS, Eckerle LD, Sims AC and Denison MR: SARS coronavirus replicase proteins in pathogenesis. Virus Res. 133:88–100. 2008.PubMed/NCBI View Article : Google Scholar | |
|
McBride R and Fielding BC: The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis. Viruses. 4:2902–2923. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Yu X, Sun S, Shi Y, Wang H, Zhao R and Sheng J: SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression. Crit Care. 24(170)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chan JF, Zhang AJ, Yuan S, Poon VK, Chan CC, Lee AC, Chan WM, Fan Z, Tsoi HW, Wen L, et al: Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: Implications for disease pathogenesis and transmissibility. Clin Infect Dis. 71:2428–2446. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Iwasaki A and Pillai PS: Innate immunity to influenza virus infection. Nat Rev Immunol. 14:315–328. 2014.PubMed/NCBI View Article : Google Scholar | |
|
van der Poll T and Opal SM: Host-pathogen interactions in sepsis. Lancet Infect Dis. 8:32–43. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Asehnoune K, Villadangos J and Hotchkiss RS: Understanding host-pathogen interaction. Intensive Care Med. 42:2084–2086. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Streicher F and Jouvenet N: Stimulation of innate immunity by host and viral RNAs. Trends Immunol. 40:1134–1148. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Totura AL and Baric RS: SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon. Curr Opin Virol. 2:264–275. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Gralinski LE, Menachery VD, Morgan AP, Totura AL, Beall A, Kocher J, Plante J, Harrison-Shostak DC, Schäfer A, Pardo-Manuel de Villena F, et al: Allelic variation in the toll-like receptor adaptor protein Ticam2 contributes to SARS-coronavirus pathogenesis in mice. G3 (Bethesda). 7:1653–1663. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK and Perlman S: Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 19:181–193. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Page C, Goicochea L, Matthews K, Zhang Y, Klover P, Holtzman MJ, Hennighausen L and Frieman M: Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection. J Virol. 86:13334–13349. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Peiris JS and Cheung CY: The macrophage in the pathogenesis of severe acute respiratory syndrome coronavirus infection. Hong Kong Med J. 15 (Suppl 6):S21–S25. 2009.PubMed/NCBI | |
|
Zhou J, Chu H, Chan JF and Yuen KY: Middle East respiratory syndrome coronavirus infection: Virus-host cell interactions and implications on pathogenesis. Virol J. 12(218)2015.PubMed/NCBI View Article : Google Scholar | |
|
Yoshikawa T, Hill T, Li K, Peters CJ and Tseng CT: Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells. J Virol. 83:3039–3048. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Eppensteiner J, Kwun J, Scheuermann U, Barbas A, Limkakeng AT, Kuchibhatla M, Elster EA, Kirk AD and Lee J: Damage- and pathogen-associated molecular patterns play differential roles in late mortality after critical illness. JCI Insight. 4(e127925)2019.PubMed/NCBI View Article : Google Scholar | |
|
Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, Wei P, Ge J, Gou M, Li X, et al: Detection of SARS-CoV-2-Specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 52:971–977.e3. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G, et al: Reduction and functional exhaustion of T cells in patients with Coronavirus disease 2019 (COVID-19). Front Immunol. 11(827)2020.PubMed/NCBI View Article : Google Scholar | |
|
Guo L, Ren L, Yang S, Xiao M, Chang Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al: Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 71:778–785. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen L, Xiong J, Bao L and Shi Y: Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis. 20:398–400. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, et al: Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 368(m1091)2020.PubMed/NCBI View Article : Google Scholar | |
|
Xie J, Tong Z, Guan X, Du B, Qiu H and Slutsky AS: Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. 46:837–840. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang F, Shi S, Zhu J, Shi J, Dai K and Chen X: Analysis of 92 deceased patients with COVID-19. J Med Virol. 92:2511–2515. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Giannitsi S, Tsinivizov P, Poulimenos LE, Kallistratos MS, Varvarousis D, Manolis AJ, Tsamakis K, Rizos E, Spandidos DA, Tsiptsios D and Triantafyllis AS: [Case Report] Stress induced (Takotsubo) cardiomyopathy triggered by the COVID-19 pandemic. Exp Ther Med. 20:2812–2814. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Germain RN: Maintaining system homeostasis: The third law of Newtonian immunology. Nat Immunol. 13:902–906. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Channappanavar R and Perlman S: . Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 39:529–539. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Fernandez-Delgado R, Castaño-Rodriguez C, Alcaraz A, Torres J, Aguilella VM and Enjuanes L: Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 10(e1004077)2014.PubMed/NCBI View Article : Google Scholar | |
|
Bermejo JF and Muñoz-Fernandez MA: Severe acute respiratory syndrome, a pathological immune response to the new coronavirus-implications for understanding of pathogenesis, therapy, design of vaccines, and epidemiology. Viral Immunol. 17:535–544. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Chousterman BG, Swirski FK and Weber GF: Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 39:517–528. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yuen KS, Ye ZW, Fung SY, Chan CP and Jin DY: SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 10(40)2020.PubMed/NCBI View Article : Google Scholar | |
|
Misra DP, Agarwal V, Gasparyan AY and Zimba O: Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 39:2055–2062. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Cecconi M, Evans L, Levy M and Rhodes A: Sepsis and septic shock. Lancet. 392:75–87. 2018.PubMed/NCBI View Article : Google Scholar | |
|
RECOVERY Collaborative Group. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, et al: Dexamethasone in hospitalized patients with Covid-19-preliminary report. N Engl J Med, 2020. | |
|
Gourd NM and Nikitas N: Multiple organ dysfunction syndrome. J Intensive Care Med. 35:1564–1575. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Padureanu R, Albu CV, Mititelu RR, Bacanoiu MV, Docea AO, Calina D, Padureanu V, Olaru G, Sandu RE, Malin RD and Buga AM: Oxidative stress and inflammation interdependence in multiple sclerosis. J Clin Med. 8(1815)2019.PubMed/NCBI View Article : Google Scholar | |
|
Laforge M, Elbim C, Frère C, Hémadi M, Massaad C, Nuss P, Benoliel JJ and Becker C: Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 20:515–516. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, Rajkovic J, TsouhFokou PV, Azzini E, Peluso I, et al: Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol. 11(694)2020.PubMed/NCBI View Article : Google Scholar | |
|
Sharifi-Rad J, Rodrigues CF, Sharopov F, Docea AO, Can Karaca A, Sharifi-Rad M, KahveciKarıncaoglu D, Gülseren G, Şenol E, Demircan E, et al: Diet, Lifestyle and cardiovascular diseases: Linking pathophysiology to cardioprotective effects of natural bioactive compounds. Int J Environ Res Public Health. 17(2326)2020.PubMed/NCBI View Article : Google Scholar | |
|
Salehi B, Rescigno A, Dettori T, Calina D, Docea AO, Singh L, Cebeci F, Özçelik B, Bhia M, Dowlati Beirami A, et al: Avocado-soybean unsaponifiables: A panoply of potentialities to be exploited. Biomolecules. 10(130)2020.PubMed/NCBI View Article : Google Scholar | |
|
Salehi B, Capanoglu E, Adrar N, Catalkaya G, Shaheen S, Jaffer M, Giri L, Suyal R, Jugran AK, Calina D, et al: Cucurbits Plants: A key emphasis to its pharmacological potential. Molecules. 24(1854)2019.PubMed/NCBI View Article : Google Scholar | |
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui D, et al: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 395:507–513. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR and Daneman N: Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin Microbiol Infect. 26:1622–1629. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al: Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 21:335–337. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Fattahi F and Ward PA: Understanding immunosuppression after sepsis. Immunity. 47:3–5. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Shenoy V, Ferreira AJ, Qi Y, Fraga-Silva RA, Díez-Freire C, Dooies A, Jun JY, Sriramula S, Mariappan N, Pourang D, et al: The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med. 182:1065–1072. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Qiu HB, Yang Y, Wang L, Ding HM and Li HP: Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat. Arch Biochem Biophys. 481:131–136. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Zhu Y, Qiu HB, Yang Y, Liu L, Zhao MM, Chen QH and Guo T: Angiotensin II type 2 receptor expression and its modulation in angiotensin II induced acute lung injury in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 20:585–587. 2008.PubMed/NCBI(In Chinese). | |
|
Imai Y, Kuba K and Penninger JM: Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cell Mol Life Sci. 64:2006–2012. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Kuba K, Imai Y and Penninger JM: Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 6:271–276. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Busse LW, Chow JH, McCurdy MT and Khanna AK: COVID-19 and the RAAS-a potential role for angiotensin II. Crit Care. 24(136)2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Zhang PS, Yu Q, Liu L, Yang Y, Guo FM and Qiu HB: Losartan inhibits conventional dendritic cell maturation and Th1 andTh17 polarization responses: Νovel mechanisms of preventive effects on lipopolysaccharide-inducedacute lung injury. Int J Mol Med. 29:269–276. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, et al: Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 323:1574–1581. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tian S, Hu W, Niu L, Liu H, Xu H and Xiao SY: Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 15:700–704. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Vasarmidi E, Tsitoura E, Spandidos DA, Tzanakis N and Antoniou KM: Pulmonary fibrosis in the aftermath of the COVID-19 era. Exp Ther Med. 20:2557–2560. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Elsayed SM, Reddy MK, Murthy PM, Gupta I, Valiuskyte M, Sánchez DF and Diaz MA: The possibility and cause of relapse after previously recovering from COVID-19: A systematic review. Cureus. 12(e10264)2020.PubMed/NCBI View Article : Google Scholar | |
|
Gousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K, Collarino R, Conrad A, Slama D, Joseph C, et al: Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound. J Infect. 81:816–846. 2020.PubMed/NCBI View Article : Google Scholar |
